Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients.
about
Progress and problems in understanding and managing primary Epstein-Barr virus infectionsTherapeutic options in post-transplant lymphoproliferative disorders.Simultaneous determination of acyclovir, ganciclovir, and (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine in human plasma using high-performance liquid chromatography.Complete response to post-transplant lymphoproliferative disorder by surgical resection and rituximab after living-donor liver re-transplantation for recurrent primary sclerosing cholangitis.Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation.longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipientsImmune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients.How I treat EBV lymphoproliferation.Transfusion-related Epstein-Barr virus infection among stem cell transplant recipients: a retrospective cohort study in children.Adoptive cellular therapy with T cells specific for EBV-derived tumor antigens.The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review.Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipients.Adapted treatment of Epstein-Barr virus infection to prevent posttransplant lymphoproliferative disorder after heart transplantation.Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the EuropeEpstein-Barr virus infections after allogeneic stem cell transplantation: a comparison between non-malignant and malignant hematological disorders.
P2860
Q24597706-FB50EF82-E8AE-403F-881E-8268F3CFF549Q30455714-0F818681-A1D0-427B-9763-6341E290DB19Q33428636-DDCB44C2-FCEE-48EF-BDE1-96AF2FD2D810Q33436410-5C2F4990-21E9-402B-A4B4-9FE4585B41FEQ34455315-52D8F0B9-0AF1-4F31-B52F-9D1D73352690Q36933028-FEF2A7A7-0322-4847-B844-E451D63062A1Q37152749-DE43D3C2-7FA7-43CD-BEE2-2C6EA8F53239Q37414678-3F79702C-6064-49CD-9AB8-225CE361FA17Q37993872-A1C408D3-CF93-4A22-BD89-7F65694EC3F8Q38570061-0D3477BB-2739-484C-8C36-B6BEC8FDBB91Q38933152-C32BE6D0-2483-4738-BD76-7670D5352A97Q40906860-E2B6E648-F396-4B50-BB5D-EBA75527E120Q42229199-B5CD9180-20B6-47FE-8849-8D952DB74665Q42258745-ACA35967-3B87-4C8E-A112-12AAE37D6CBCQ43689745-19630219-A6E7-4918-A28F-AE451C4852C2
P2860
Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Adolescents are more likely to ...... r renal transplant recipients.
@en
Adolescents are more likely to ...... r renal transplant recipients.
@nl
type
label
Adolescents are more likely to ...... r renal transplant recipients.
@en
Adolescents are more likely to ...... r renal transplant recipients.
@nl
prefLabel
Adolescents are more likely to ...... r renal transplant recipients.
@en
Adolescents are more likely to ...... r renal transplant recipients.
@nl
P2093
P1433
P1476
Adolescents are more likely to ...... r renal transplant recipients.
@en
P2093
Connie L Davis
Jodi M Smith
Lawrence Corey
Patrick J Healey
Ruth A McDonald
P304
P356
10.1097/01.TP.0000265914.16491.7D
P577
2007-06-01T00:00:00Z